Lipopolysaccharide (LPS) has been long known to promote neuroinflammation and learning and memory deficits. Since spermine, one of the main natural polyamines in the central nervous system, protects from LPSinduced memory deficit by a mechanism that comprises GluN2B receptors, the aim of the present study was to determine whether brain-derived neurotrophic factor (BDNF), tropomyosin-related kinase B (TrkB) receptor and cAMP response element binding (CREB) are involved in this protective effect of spermine. Adult male Swiss albino mice received, immediately after training in the novel object recognition task, saline or LPS (250 μg/kg, i.p.); 5 min later they received saline or spermine (0.3 mg/kg, i.p.) and, when specified, 5 min thereafter saline or the TrkB receptor antagonist ANA-12 (0.5 mg/kg, i.p.) in different flanks. Animals were tested 24 h after training. Spermine protected from LPS-induced memory deficit and this protective effect was reversed by ANA-12. In a subset of animals BDNF, CREB and phospho-CREB immunoreactivity was determined in the hippocampi and cerebral cortex 4 h after spermine injection. Spermine reversed the decrease of mature BDNF levels induced by LPS in both hippocampus and cerebral cortex. Spermine increased phospho-CREB content and phospho-CREB/total CREB ratio in the cerebral cortex of LPS-treated mice. The results support that the protective effect of spermine on LPS-induced memory deficits depends on TrkB receptor activation and is accompanied by restoration of mature BDNF levels in hippocampus and cerebral cortex, as well as increased CREB phosphorylation in the cerebral cortex.
Introduction
Neuroinflammation plays a significant role in several neurodegenerative diseases in which learning and memory deficits are a hallmark (Eikelenboom, Bate, Van Gool, Hoozemans et al., 2002; Liraz-Zaltsman, Yaka, Shabashov, Shohami et al., 2016) . Peripheral inflammation induced by intraperitoneal (i.p.) injection of the Toll-like receptor (TLR)-4 agonist lipopolysaccharide (LPS) triggers neuroinflammation, leading to learning and memory deficits (Carvalho, Gutierres, Bueno, Agostinho et al., 2016; Fruhauf, Ineu, Tomazi, Duarte et al., 2015; Tarr, McLinden, Kranjac, Kohman et al., 2011; Thomson and Sutherland, 2005) . In addition, LPS induces the release of neurotoxic substances and suppresses the secretion of neurotrophic factors, which may contribute for hindered neuroplasticity and consequent cognitive deficit in these animals (Yirmiya and Goshen, 2011) .
Current evidence supports a major role for brain-derived neurotrophic factor (BDNF) (Alberini and Kandel, 2014) in memory formation and retrieval (Bekinschtein, Cammarota, and Medina, 2014) . It has been shown that the BDNF gene deletion in the hippocampus impairs spatial learning in the water maze as well as novel object recognition (Heldt, Stanek, Chhatwal, and Ressler, 2007) . In fact, BDNF levels are decreased in several neurodegenerative diseases in which cognitive deficit has been reported (Bathina and Das, 2015) , such as Alzheimer's (Phillips, Hains, Armanini, Laramee et al., 1991 ), Parkinson's (Howells, Porritt, Wong, Batchelor et al., 2000; Robbins and Cools, 2014) , and Huntington's disease (Lawrence, Watkins, Sahakian, Hodges et al., 2000) .
BDNF is the most abundant neurotrophic factor in the adult brain, particularly in the hippocampus and cerebral cortex (Liu, Shen, Yuan, Guo et al., 2015) . BDNF is synthesized and released by nerve cells in an activity-dependent manner (Chen, Xiong, Tong, and Mao, 2013) . For instance, while glutamate stimulates BDNF expression, gamma aminobutyric acid (GABA) suppresses it (Porcher, Hatchett, Longbottom, McAinch et al., 2011) . BDNF is synthesized as pro-BDNF and then cleaved into mature BDNF within the endoplasmic reticulum by furin and/or in regulated secretory vesicles by protein convertase 1 (Mowla, Farhadi, Pareek, Atwal et al., 2001; Rodier, Prigent-Tessier, Bejot, Jacquin et al., 2014) . BDNF may also be cleaved in the extracellular milieu by tissue plasminogen activator (t-PA) plasmin (Pang, Teng, Zaitsev, Woo et al., 2004) . Interestingly, while t-PA gene disruption impairs (Frey, Muller, and Kuhl, 1996; Pawlak, Nagai, Urano, Napiorkowska-Pawlak et al., 2002) , t-PA overexpression improves learning (Madani et al., 1999; Pawlak et al., 2002) , supporting a role for extracellular BDNF processing in learning and memory. A large body of evidence suggests that pro-and mature BDNF interact with different receptor/signaling systems, triggering opposite effects on neuronal survival and plasticity (Kaplan and Miller, 2000; Lee, Kermani, Teng, and Hempstead, 2001; Lu, Pang, and Woo, 2005; Rodier et al., 2014) . The mature form of BDNF binds to the tropomyosin-related kinase B (TrkB) receptor (Michalski and Fahnestock, 2003) and promotes synaptic growth in the developing and adult brain (Tanila, 2016) , strengthening synaptic transmission and synaptic plasticity (Lu, Nagappan, and Lu, 2014) . On the other hand, pro-BDNF binds to p75 receptor and activates neuronal apoptotic pathways (Teng, Teng, Lee, Wright et al., 2005) . Accordingly, while TrkB overexpression enhances memory (Koponen, Voikar, Riekki, Saarelainen et al., 2004) , reduced BDNF/TrkB signaling is associated with impaired spatial memory (Minichiello, Korte, Wolfer, Kuhn et al., 1999; Saarelainen, Pussinen, Koponen, Alhonen et al., 2000) . Cyclic AMP (cAMP)-responsive element-binding protein (CREB), a transcription factor that has been implicated in memory formation and enhancement (Kida and Serita, 2014) , increases BDNF expression (Suzuki, Fukushima, Mukawa, Toyoda et al., 2011) . Accordingly, CREB upregulation promotes memory consolidation (Alberini and Kandel, 2014; Zhou et al., 2009 ) and facilitates the conversion of short term memory (STM) to long term memory (LTM) (Lobos, Altmann, Mengod, Weiss, Rudin, Karam, 1990; Vogt et al., 2014) .
In fact, the genetic loss of CREB function impairs LTM, but not STM (Kim, Kwon, Kim, and Han, 2013; Vogt et al., 2014) . Therefore, CREB has been considered a molecular switch for memory formation (Kandel, 2012) . Phosphorylated CREB, the active form of this transcription factor, induces the transcription of memory-associated genes (OrtegaMartinez, 2015) , such as c-fos, Arc and BDNF (Alberini and Kandel, 2014; Kandel, 2012; Miyamoto, 2006) .
Evidence suggests that spermidine and spermine, natural polyamines, may improve learning and memory (Berlese, Sauzem, Carati, Guerra et al., 2005; Fruhauf et al., 2015; Guerra, Rubin, and Mello, 2016; Kishi, Ohno, and Watanabe, 1998; Rubin, Berlese, Stiegemeier, Volkweis et al., 2004; Rubin, Boemo, Jurach, Rojas et al., 2000; Signor, Temp, Mello, Oliveira et al., 2016) by interacting with the polyaminebinding site at the NMDA receptor (Mony, Zhu, Carvalho, and Paoletti, 2011) . In addition it has been shown that spermine attenuates memory deficits induced by different amnesic agents (Fruhauf et al., 2015; Kishi et al., 1998; Mikolajczak, Okulicz-Kozaryn, Kaminska, Niedopad et al., 2002; Velloso, Dalmolin, Gomes, Rubin et al., 2009) .
It is interesting to note that spermidine-induced facilitation of memory consolidation involves the sequential activation of protein kinase C and protein kinase A A/CREB signaling in the hippocampus of rats (Guerra, Mello, Bochi, Pazini et al., 2011 , 2012 . Moreover, the facilitatory effect of spermidine on memory is associated with increased levels of mature BDNF in the hippocampus (Signor, Girardi, Lorena Wendel, Fruhauf et al., 2017) . Though spermine reverses the cognitive deficiency induced by lipopolysaccharide (LPS) (Fruhauf et al., 2015) , no study has addressed whether CREB, BDNF and TrkB receptor activation are involved in the protective effect of spermine from LPSinduced memory impairment.
Methods

Subjects
Adult male Swiss albino mice with approximately 12 weeks of age (30 to 35 g), provided by the Animal center of the Universidade Federal de Santa Maria were used. The animals had free access to water and food (Guabi, Santa Maria, Rio Grande do Sul, Brazil), and were kept in a room with controlled humidity and temperature (22 ± 2°C) with a 12-h light-dark cycle. Behavioral experiments were carried out during the light phase of the cycle (between 9:00 a.m. and 5:00 p.m.) in a soundattenuated and air-regulated room, where the animals were habituated for 1 h prior to experiments. All animal procedures were carried out in accordance with Brazilian law n•. 11.794/2008, which is in agreement with the policies on the use of animals and humans in neuroscience research, revised and approved by the Society for Neuroscience in January 1995 and with the Institutional and National regulations for animal research (process 6272010415).
Drugs
Lipopolysaccharide (Escherichia coli, serotype 055:B5), spermine (N, N′-bis (3-aminopropyl) 1,4-butanediamine) and ANA-12 (TrkB antagonist,
thiophene-2-carboxamide) were obtained from Sigma (St. Louis, MO, USA). All drug solutions were prepared on a daily basis, in saline (0.9% NaCl).
Object recognition arena
The novel object recognition task was carried out as described by (Gomes, Dalmolin, Bar, Karpova et al., 2014) . The task was performed in a 30 × 30 × 30 cm wood chamber, which had its walls painted black, a front wall made of Plexiglas and a floor covered with ethyl vinyl acetate sheet. Illumination (about 40 lux) was provided by a light bulb hanging 60 cm above the apparatus. The temperature of the room was maintained at 22°C by an air-conditioner that also provided background sound. The objects used in the experiment were plastic mounting bricks, each having particular shape and color, but the same size.
Experimental groups
2.4.1. Experiment 1: novel object recognition task Experiment 1 was devised to investigate the involvement of the TrkB receptor in the protective effect of spermine on LPS-induced memory deficit in the object recognition task. The task consisted of three sessions: habituation, training and test. In the habituation session, mice were individually familiarized to the behavioral apparatus for 10 min and returned to their home cages. Twenty-four hours later the animals were subjected to the training session, in which they were exposed to two of the same objects (object A) for 8 min. The time spent exploring each object was recorded with two stopwatches. Exploration was considered when the animal touched or approached the object with the nose at a distance of < 2 cm. Sitting on or climbing the object was not considered as exploration. The test session, which lasted 5 min, was carried out 24 h after training. Mice were returned to the behavioral chamber, in which a novel object (object B) substituted one of the familiar objects (object A). The time spent exploring the familiar and the novel object were recorded and a recognition index (percent of exploratory behavior directed to the novel object) was calculated {[(T novel − T familiar )/(T novel + T familiar )] × 100 (%)}, and used as a memory parameter. The objects were used counterbalancedly throughout the experiments. The animals did not present previous preference to any of the objects (Fruhauf et al., 2015) . Chamber and objects were cleaned with a 30% ethanol solution immediately before and after each behavioral session.
Animals were habituated and trained as described above. Immediately after training, the animals were injected with saline or LPS (250 μg/kg). This dose of LPS does not alter locomotor activity 24 h after its injection (Fruhauf et al., 2015) . Five minutes thereafter they were injected with saline or spermine (0.3 mg/kg, a dose that reverses LPS-induced memory impairment). Five minutes after spermine (or saline) injection, the animals received saline or ANA-12, a TrkB antagonist (0.5 mg/kg, a dose that does not affect memory per se) in the opposite flank. Twenty-four hours after training the animals were subjected to the novel object recognition test session, as previously described. All injections were performed intraperitoneally in a 5 ml/kg injection volume. The doses were selected based on the previous studies of Fruhauf et al. (2015) and Cazorla, Premont, Mann, Girard et al. (2011) 
Experiment 2: BDNF measurement
Experiment 2 was designed to evaluate the involvement of total and mature BDNF in the protective effect of spermine on LPS-induced memory deficit. Animals were trained in the novel object recognition apparatus and injected, immediately post-training, with saline or LPS (250 μg/kg). Five minutes later, they were injected with saline or spermine (0.3 mg/kg) in different flanks. Four hours (Kranjac, Koster, Kahn, Eimerbrink et al., 2013) after spermine administration the animals were euthanized by cervical dislocation and the whole hippocampi and cerebral cortex were dissected and homogenized 1:10 w/v in lysis buffer containing 137 mM NaCl, 20 mM Tris-HCl (pH 8.0) 10% glycerol, 1 mM PMSF, 0.5 mM sodium vanadate and protease and phosphatase inhibitors (Sigma, St. Louis, MO). Total BDNF quantification was carried out by regular Mouse BDNF ELISA Kit (GenWay) in samples treated with 1 N HCl (pH 2.5), according to the manufacturer procedures. For mature BDNF quantification, samples were not treated with HCl. The optical densities were determined at 450 nm in a microplate reader (Molecular Devices, Sunnyvale, CA).
Experiment 3: Western blot assay
Experiment 3 aimed at investigating the involvement of CREB in the protective effect of spermine on LPS-induced memory deficit. Animals were trained in the novel object recognition apparatus and injected, immediately post-training, with saline or LPS (250 μg/kg). Five minutes later they were injected with saline or spermine (0.3 mg/kg) in the opposite flank. The animals were euthanized by cervical dislocation 4 h after spermine injection, because the levels of cAMP peak 180-360 min after training in cognitive tasks (Bernabeu, Schmitz, Faillace, Izquierdo et al., 1996) , and the whole hippocampi and cerebral cortex were dissected on ice. Cerebral structures were homogenized in a lysis buffer which contained 10 mM HEPES (pH 7.9), 10 mM KCl, 2 mM MgCl 2 , 1 mM EDTA, 1 mM NaF, 1 mM phenylmethanesulphonyl fluoride, 10 mM β-glycerophosphate, 1 mM DTT and 2 mM sodium orthovanadate, and a mixture of protease and phosphatase inhibitors (Sigma-Aldrich). The homogenates were then centrifuged (12.700g for 30 min at 4°C) and the supernatant (S1), denominated cytosolic fraction, was reserved for subsequent processing. The pellet (P1) was resuspended in lysis buffer with Triton-X 100 (1% final concentration), incubated for 15 min on ice, and centrifuged at 12.700g for 60 min at 4°C. The supernatant (S2) was discarded, and the pellet (P2) was resuspended in a buffer containing 50 mM KCl, 2 mM MgCl 2 , 1 mM EDTA, 1 mM NaF, 10 µg/mL aprotinin, 10 mM β-glycerolphosphate, 1 mM PMSF, 1 mM DTT, 2 mM sodium orthovanadate, 420 mM NaCl, and 25% glycerol in 20 mM HEPES, pH 7.9. Samples were incubated for 15 min on ice and centrifuged at 12.700g for 30 min at 4°C. The supernatant (S3) was considered the nuclear fraction. Protein concentration in the cytosolic and nuclear fraction was measured by the bicinchonic acid assay (BCA) using bovine serum albumin as standard (Pierce, Rockford, IL, USA). Cytosolic and nuclear fractions (20 μg protein) were added to 0.2 volumes of concentrated loading buffer (200 mM Tris, 10% glycerol, 2% SDS, 2.75 mM β-mercaptoethanol, and 0.04% bromophenol blue) and boiled for 10 min. Proteins were resolved by 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and electroblotted onto nitrocellulose membranes (Millipore). Membranes were blocked with 5% bovine serum albumin (BSA) in TBS-T (0.05% Tween 20 in Tris-borate saline) plus 5% non-fat milk at room temperature for 1 h, then incubated overnight at 4°C with primary antibodies: rabbit anti-CREB (ser 133) (1:10000, sc-25786, Santa Cruz Biotechnology), rabbit anti-phospho-CREB (1:10000, sc-7978, Santa Cruz Biotechnology) were blocked only with 5% BSA. This procedure was followed by incubation with horseradish peroxidase-conjugated secondary antibody (1:6000, sc-2768, Santa Cruz Biotechnology) at room temperature for 3 h. Blots were developed by enhanced chemiluminescence (ECL) (Thermo Fisher Scientific, Rockford, IL, USA) and band intensities were quantified by ImageJ 219 (NIH). In these experiments, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (anti-GAPDH, 1:50000, G9295, Sigma-Aldrich) was used as an internal reference (loading control). The results were normalized for the control group densitometry values and expressed as the relative amount of phosphorylated and non-phosphorylated forms, and the phosphorylated/total ratio.
Statistical analysis
Data analysis was executed using two or three-way analysis of variance (ANOVA), depending on the experimental design. The Bonferroni's test was used for post hoc analysis, when indicated. A p < 0.05 was considered significant.
Results
TrkB receptor antagonist blocks the protective effect of spermine on LPS-induced memory deficit
The effect of ANA-12 on the protective effect of spermine from LPSinduced memory deficit in the object recognition task is shown in Fig. 1 . Statistical analysis (three-way ANOVA) showed a significant pretreatment (saline or LPS) versus treatment (saline or spermine) versus TrkB receptor antagonist (saline or ANA-12) interaction [F (1,61) = 5.68; p < 0.05]. Post-hoc analysis (Bonferroni's Test) showed that LPS impairs memory consolidation of this task and that spermine administration prevents LPS-induced memory impairment. It also showed that ANA-12 reversed the protective effect of spermine from LPS-induced memory impairment in the novel object recognition task. ANA-12 and spermine had no effect per se on the performance of the animals in the task.
BDNF measurement
3.2.1. LPS decreased total BDNF levels in the cerebral cortex Fig. 2A and C shows the effect of LPS and spermine on the total BDNF levels in the hippocampus and cerebral cortex. Statistical analysis (two-way ANOVA) showed a significant effect of treatment (saline or spermine) in the hippocampus (F (1, 16) = 9.36; p < 0.05; Fig. 2A ) and pretreatment (LPS or saline) in the cerebral cortex (F (1, 16) = 8.17; p < 0.05; Fig. 2C ). Post-hoc analyses (Bonferroni's Test) showed that spermine increased the levels of total BDNF in the hippocampus and that LPS decreased total BDNF levels in the cerebral cortex.
Spermine restores LPS-decreased mature BDNF levels in hippocampus and cerebral cortex
Fig . 2B and 2D shows the effect of post-training administration of spermine on LPS-induced decreased of mature BDNF in the hippocampus and cerebral cortex. Statistical analysis (two-way ANOVA) revealed a significant pretreatment (saline or LPS) versus treatment (saline or spermine) interaction in the hippocampus (F (1, 19) = 5.831; p < 0.05; Fig. 2B ) and cerebral cortex (F (1, 19) = 12.14; p < 0.05; Fig. 2D ). Post-hoc analyses (Bonferroni's Test) showed that LPS decreased the levels of mature BDNF in the hippocampus and cerebral cortex, and that spermine restores mature BDNF levels in both structures.
3.3. Spermine increases phospho-CREB (ser133) and phospho-CREB/total-CREB ratio in cerebral cortex of LPS-treated mice Fig. 3 depicts the effect of spermine (0.3 mg/kg), LPS (250 μg/kg), and the administration of spermine and LPS immediately after training on CREB levels and phosphorylation. Statistical analysis (two-way ANOVA) revealed that the administration of spermine, LPS or their combination did not alter the total CREB levels in hippocampus or cerebral cortex (Fig. 3A) . On the other hand, spermine administration increased the phospho-CREB immunoreactivity in the cerebral cortex of LPS-treated mice, revealed by a significant pretreatment (saline or LPS) versus treatment (saline or spermine) interaction [F (1, 30) = 7.95; p < 0.05; Fig. 3B ]. Spermine increased phospho-CREB/total-CREB ratio (Fig. 3C) in the cerebral cortex of animals treated with LPS, as revealed by a significant pretreatment (saline or LPS) versus treatment (saline or spermine) interaction [F (1, 30) = 4.86; p < 0.05].
Discussion
In this study we show experimental evidence that the protection provided by spermine from LPS-induced memory impairment involves BDNF and TrkB receptor activation. Accordingly, the protective effect of spermine on LPS-induced memory deficit was blocked by the TrkB antagonist ANA-12; spermine increased total BDNF levels in the hippocampus; reversed the LPS-induced decrease of mature BDNF levels in the hippocampus and cerebral cortex, and increased CREB phosphorylation in the cerebral cortex of mice treated with LPS.
It is interesting that though LPS did not alter total BDNF levels, it significantly reduced mature BDNF levels in the cerebral cortex and hippocampus. These results are in agreement with those from Shaw et al. (2001), who have shown that LPS (100 µg/kg) does not alter total BDNF levels in the dentate gyrus, but causes cognitive deficits. In line with this view, Ge et al. (2015) have shown that systemic LPS does not alter total BDNF levels but decreases phosphoCREB, another finding of the current study. In addition, data from spontaneously hypertensive rats and in cell culture (SH-SY5Y cells) corroborate the view that LPS decreases BDNF (Goel, Bhat, Hanif, Nath et al., 2017; Lee, Lim, Ko, Jeong et al., 2017) and phosphoCREB signaling (Lee et al., 2017) . The current finding that a TrkB antagonist reverses the protective effect of spermine on LPS-induced memory deficit, to some degree, supports the claim that BDNF/TrkB signaling plays an important role in cognitive function (Hock, Heese, Hulette, Rosenberg et al., 2000; Peng, Wuu, Mufson, and Fahnestock, 2005; Phillips et al., 1991; Wang, Li, Yun, Zhuang et al., 2017) and that its decline is associated with learning and memory deficits (Devi and Ohno, 2015) . Interestingly, it has been shown that TrkB depletion increases mnemonic dysfunction in animal models of Alzheimer's disease (Devi and Ohno, 2015; Peng et al., 2005; Yang, Harte-Hargrove, Siao, Marinic et al., 2014) . Current evidence indicates that CREB modulates memory by increasing BDNF expression (Suzuki et al., 2011) . Activated CREB initiates the transcription of genes such as activity-regulated cytoskeleton associated protein (Arc), c-fos, and brain-derived neurotrophic factor (BDNF) (Finkbeiner, Tavazoie, Maloratsky, Jacobs et al., 1997; Kawashima, Okuno, Nonaka, AdachiMorishima et al., 2009; Sheng, Thompson, and Greenberg, 1991) , which have been implicated in learning and memory (Kandel, 2012; Kida and Serita, 2014) . CREB activation depends on its phosphorylation at serine 133 (S133) domain (Silva, Kogan, Frankland, and Kida, 1998) by various cellular kinases, including protein kinase A (Bernabeu, Bevilaqua, Ardenghi, Bromberg et al., 1997; Gonzalez and Montminy, 1989) , protein kinase C (Yamamoto, Acevedo-Duncan, Chalfant, Patel et al., 1998) , calcium-calmodulin kinase II (Sun, Enslen, Myung, and Maurer, 1994) and MAP kinase-activated protein kinase 2 (MAPKAP2) (Tan, Rouse, Zhang, Cariati et al., 1996) . NMDAr-associated intracellular signaling results in the activation of multiple protein targets, such as PKA (Bernabeu et al., 1997; Chetkovich and Sweatt, 1993; Chetkovich, Gray, Johnston, and Sweatt, 1991) . Since NMDA receptormediated Ca 2+ influx (Chetkovich et al., 1991) activates cAMP/PKA pathway, it is very possible that it sequentially stimulates adenylate cyclase (AC) activity, cAMP accumulation and PKA activation, culminating in CREB phosphorylation (Eliot, Dudai, Kandel, and Abrams, 1989; Poser and Storm, 2001) . Spermine is one the main natural polyamines in the central nervous system, whose concentration in synaptic vesicles achieves 1.5-2.8 mM Fig. 1 . Effect of ANA-12 (ANA) on the recognition index (%) of mice treated with lipopolysaccharide (LPS) and spermine (SPM). Immediately after training, the animals were injected with saline (Sal) or LPS (250 μg/kg, i.p.), 5 min later they were injected with Sal or SPM (0.3 mg/kg, i.p.), and 5 min after that they were injected with Sal or ANA (0.5 mg/kg, i.p.) in different flanks, and tested 24 h later. Data are the mean ± S.E.M. of 8-10 animals per group. * p < 0.05 compared with control group Sal/Sal/Sal, # p < 0.05 compared with LPS/Sal/Sal group, @ p < 0.05 compared with LPS/SPM/Sal group (three-way ANOVA followed by Bonferroni post hoc test). (Masuko, Kusama-Eguchi, Sakata, Kusama et al., 2003) . Interestingly, spermine synthase deficiency is associated with the Snyder-Robinson syndrome, an X-linked mental retardation disorder (Cason, Ikeguchi, Skinner, Wood et al., 2003) in which the affected patients present low levels of intracellular spermine in lymphocytes and fibroblasts with corresponding increased spermidine/spermine ratios (Cason et al., 2003) . The existence of an inborn error of the metabolism characterized by mental retardation due to impaired spermine synthesis suggests that spermine may play a role in cognitive function and brain development.
In line with this view, the immediately post-training intrastriatal injection of a low dose of spermine (0.1 nmol) reverts the deleterious effect of quinolinic acid on the memory of the object recognition task (Velloso et al., 2009) . Moreover, the effect of systemically administered spermine on the memory of object recognition task of mice is characterized by an inverted "U" dose-effect curve, with the maximal effect (memory improvement) being observed at the dose of 1 mg/kg (Fruhauf et al., 2015) . Fruhauf et al. (2015) have also shown that spermine at the dose of 0.3 mg/kg reverses LPS-induced memory impairment. The finding that LPS decreases mature BDNF levels in the cerebral cortex and hippocampus, and that spermine brings them back to control levels, to some extent, corroborate the currently reported blockade of the protective effect of spermine on the memory of LPS-injected animals by ANA-12 (Fig. 1) , because mature BDNF elicits TrkB-mediated responses (Segal, 2003) . Therefore, our findings suggest that the protective effect of spermine on memory is associated with increased levels of mature BDNF and depends on the activation of the TrkB receptor. Considering that ANA-12 is known to have anxiolytic effects per se, one might argue that the reversal of the protective effect of spermine on memory by ANA-12 is related to this property of the drug. However, since behavioral testing was performed 24 h after drug administration, an anxiolytic activity is unlikely in our assay. Moreover, ANA-12 is rapidly metabolized and, therefore, it also sounds unlikely that biologically active concentrations of ANA-12 will persist in the brain 24 h after its administration (Cazorla et al., 2011) . However, we cannot rule out that a long-lasting anxiolytic effect of ANA-12 may have occurred in our experiment and contributed to its behavioral effects. One possible explanation for a TrkB-mediated effect of spermine on memory is that it increased the total amount of BDNF in the hippocampus, facilitating its conversion to mature BDNF. On the other hand, spermine did not increase total BDNF levels in the cerebral cortex (Fig. 2C ), but reverted LPS-induced decrease of mature BDNF in that structure. Therefore, one might propose that spermine facilitates the conversion of proBDNF to its mature form by mechanisms other than increased substrate availability, and this mechanism remains to be investigated.
In several aspects, the effects of spermine on memory resemble those of spermidine, including the reversal of its effects by NMDAr antagonists, supporting a role for the NMDA receptor in its effects (Fruhauf et al., 2015; Signor et al., 2014) . Consistent with this view, Fig. 3 . Effect of lipopolysaccharide (LPS) and spermine (SPM) on total CREB (A) and phosphoCREB (B) immunoreactivity, and phosphoCREB/total CREB ratio (C) in the hippocampus and cerebral cortex. Representative images of Western immunoblotting are shown. Immediately after training, mice were injected with saline (Sal) or LPS (250 μg/kg, i.p.), 5 min later they were injected with Sal or SPM (0.3 mg/kg, i.p.). Mice were euthanized 4 h after SPM injection. Data were normalized by the densitometry values of the control (Sal/Sal) group. GAPDH immunoreactivity was used as a loading control. Data are the mean ± S.E.M. for 8-9 animals in each group. recent evidence indicates the participation of PKA/CREB pathway cascade in the facilitation of memory induced by spermidine (2016; Guerra et al., 2011) . Since both polyamines activate the NMDA receptor by binding at the same dimer interface between GluN1 and GluN2B Nterminal domains (Mony et al., 2011) , spermine may analogously bind at NMDA receptor and trigger PKA activation (Guerra et al., 2011) and CREB phosphorylation (Guerra et al., 2011) . Indeed, the NMDAr has been implicated in the memory facilitation induced by spermidine (Signor et al., 2014) and spermine (Fruhauf et al., 2015) . However, there are some discrepancies on the effects of spermine and spermidine on CREB phosphorylation and BDNF immunoreactivity. While intrahippocampal spermidine increases pCREB and mature BDNF immunoreactivity in the hippocampus (Guerra et al., 2011; Signor et al., 2017) , systemic spermine increases pCREB in the cerebral cortex of animals injected with LPS and total BDNF in the hippocampus. One must also consider, however, that the route of administration of the polyamines were different among these studies, as well as the experimental animal used (rats and mice). Since in the studies of Guerra et al. (2011) and Signor et al. (2017) spermidine was infused into the CA1 area of the hippocampus, it is expected that the effects of spermidine would be more pronounced in that cerebral structure. In summary, it is possible that these methodological differences may have accounted for the discrepancies on the effect of spermine and spermidine on CREB phosphorylation and BDNF immunoreactivity among the studies of Guerra et al. (2011 ), Signor et al. (2017 and the current study. It is also worth pointing out that though spermine and spermidine seem to have similar effects on NMDAr activity (Camera, Mello, Ceretta, and Rubin, 2007; Ribeiro, Mello, Signor, and Rubin, 2013; Rubin et al., 2000 Rubin et al., , 2004 Rubin, Stiegemeier, Volkweis, Oliveira et al., 2001; Signor et al., 2016) and subsequent CREB signaling (Guerra et al., 2016 (Guerra et al., , 2011 (Guerra et al., , 2012 , there are biological functions in which spermidine does not substitute for spermine (Cason et al., 2003) . In fact, current evidence suggests that the spermine: spermidine ratio is critical for normal growth and development (Pegg, 2016) . The brain structures analyzed in this work, hippocampus and cerebral cortex, are recognized as important for memory formation (Martinez, Villar, Ballarini, and Viola, 2014; Squire, 1992) and are severely impaired by systemic LPS injection (Lee, Lee, Yuk, Choi et al., 2008; Zarifkar, Choopani, Ghasemi, Naghdi et al., 2010) . However, we cannot rule out that LPS is causing memory deficit by acting on other structures involved in learning and memory. For instance LPS-induced increase of iNOS, COX-2, IL-1β and IL-6 mRNA in the hypothalamus and amygdala (Araki, Hiraki, and Yabe, 2014) may also contribute for the deleterious effect of this toxin.
In conclusion, our study provides experimental evidence that the protection provided by spermine from LPS-induced memory impairment involves phospho-CREB, BDNF and TrkB receptor activation. However, it is still to be determined whether facilitating BDNF signaling is an adequate strategy to prevent neuroinflammation-induced cognitive deficits, particularly because BDNF overexpression in the hippocampus has been associated with seizures and death (Wang et al., 2017) .
